0001950047-24-001947.txt : 20240306 0001950047-24-001947.hdr.sgml : 20240306 20240306162234 ACCESSION NUMBER: 0001950047-24-001947 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240306 DATE AS OF CHANGE: 20240306 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Entrada Therapeutics, Inc. CENTRAL INDEX KEY: 0001689375 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 813983399 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-40969 FILM NUMBER: 24726209 BUSINESS ADDRESS: STREET 1: ONE DESIGN CENTER PLACE STREET 2: SUITE 17-500 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-305-1825 MAIL ADDRESS: STREET 1: ONE DESIGN CENTER PLACE STREET 2: SUITE 17-500 CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: CycloPorters, Inc. DATE OF NAME CHANGE: 20161104 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Dowden Nathan J CENTRAL INDEX KEY: 0001873392 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 6 TIDE STREET CITY: BOSTON STATE: MA ZIP: 02210 144 1 primary_doc.xml 144 0001873392 XXXXXXXX LIVE 0001689375 ENTRADA THERAPEUTICS INC 001-40969 One Design Center Place, Suite 17-500 Boston MA 02210 8575209158 NATHAN DOWDEN Officer COMMON Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

1826 22423.28 33368078 03/06/2024 NASDAQ Common 03/01/2024 Restricted Stock Units Issuer N 1826 03/01/2024 N/A Y 03/06/2024 03/20/2023 /s/ Nathan Dowden